Glycopyrronium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00986 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | irritable bowel syndrome | KG + DL |
| 2 | cauda equina syndrome | KG + DL |
| 3 | obsolete neurogenic bladder (disease) | KG + DL |
| 4 | neurocirculatory asthenia | KG + DL |
| 5 | migraine disorder | KG + DL |
| 6 | migraine with brainstem aura | KG + DL |
| 7 | open-angle glaucoma | KG + DL |
| 8 | autonomic nervous system disease | KG + DL |
| 9 | primary hereditary glaucoma | KG + DL |
| 10 | dysthymic disorder | KG + DL |
| 11 | common cold | KG + DL |
| 12 | dysautonomia | KG + DL |
| 13 | headache disorder | KG + DL |
| 14 | familial mitral valve prolapse | KG + DL |
| 15 | mitral valve prolapse (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.